Twitxy
Saved
@CircOutcomes's profile picture
View on X

Circ: PHO

@CircOutcomes

Circulation: Population Health and Outcomes, an American Heart Association journal. RT/follows do not imply endorsement.
ahajournals.org/journal/circou… Joined September 2013
5.2K Following 15K Followers 9.4K Posts

Latest posts 5

Circ: PHO @CircOutcomes
ICYMI: 📍Featured Science Presentation @ #ScientificSessions26 | Simultaneous Publication in @CircOutcomes

The Lp(a)FRONTIERS EXPANSION Study

@kcferdmd et al

🔗ahajournals.org/doi/10.1161/CI…
www.ahajournals.org Efficacy and Safety of Pelacarsen in Black/African American and Hispanic Participants with Elevated... Background: Black and Hispanic individuals may experience a disproportionate burden of lipoprotein(a) [Lp(a)]-associated atherosclerotic cardiovascular disease (ASCVD) risk, and ASCVD-related...
Circ: PHO @CircOutcomes 21h
Sim pub #ScientificSessions26

1st dedicated RCT of Lp(a)-lowering therapy in US Black/African American &Hispanic adults w/ Lp(a) >125 & ASCVD

Lp(a)FRONTIERS EXPANSION (n=422),monthly pelacarsen 80 mg led to an 86% placebo-adjusted Lp(a)reduction at week 52 & was well tolerated
View quoted post on X
Circ: PHO @CircOutcomes
Don't miss the accompanying Editorial by @hsbhatia:
Lp(a)FRONTIERS EXPANSION: Raising the Bar for Cardiovascular Clinical Trials #ScientificSessions26

🔗ahajournals.org/doi/10.1161/CI…

@AHAScience @kardiologykazi @iamritu @kcferdmd
www.ahajournals.org Lp(a)FRONTIERS EXPANSION: Raising the Bar for Cardiovascular Clinical Trials | Circulation:...
Circ: PHO @CircOutcomes 21h
Sim pub #ScientificSessions26

1st dedicated RCT of Lp(a)-lowering therapy in US Black/African American &Hispanic adults w/ Lp(a) >125 & ASCVD

Lp(a)FRONTIERS EXPANSION (n=422),monthly pelacarsen 80 mg led to an 86% placebo-adjusted Lp(a)reduction at week 52 & was well tolerated
View quoted post on X